US Map / Idaho

State ID

Clinical Trials in Idaho

Idaho is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Idaho and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials

41

Recruiting Now

41

← Back to US Map

Top Conditions in Idaho

Clostridioides Difficile Infection (2)Acute Respiratory Distress Syndrome (ARDS) (2)ARDS (2)ARDS (Acute Respiratory Distress Syndrome) (2)Acute Respiratory Distress Syndrome (2)Stage IIIB Lung Cancer AJCC v8 (2)Small Lymphocytic Lymphoma (2)Acute Myeloid Leukemia (1)Pleural Biphasic Mesothelioma (1)Pleural Sarcomatoid Mesothelioma (1)Clostridium Difficile (1)Clostridium Difficile Infections (1)

Frequently Asked Questions — Clinical Trials in Idaho

How many clinical trials are currently recruiting in Idaho?

ClinicalMetric currently tracks 41 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 41. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Idaho?

Idaho hosts clinical trials across a broad range of medical conditions, including Clostridioides Difficile Infection, Acute Respiratory Distress Syndrome (ARDS), ARDS, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Idaho?

To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Idaho

NCT04293562 Phase 3

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...

Acute Myeloid Leukemia

United States, Australia, Canada

Children's Oncology Group

NCT05647265 Phase 2

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...

Pleural Biphasic Mesothelioma

Alliance for Clinical Trials i

NCT06237452 Phase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile

United States, Australia, Belgium

Vedanta Biosciences, Inc.

NCT06112418 N/A

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...

Diabetes Mellitus, Type 2

NCT05636176 Phase 3

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People...

United States, Argentina, Australia

Novo Nordisk A/S

NCT07198074 Phase 3

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...

Advanced Endometrial Carcinoma

National Cancer Institute (NCI

NCT05633615 Phase 2

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refra...

Diffuse Large B-Cell Lymphoma

SWOG Cancer Research Network

NCT07000084 Phase 3

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BC...

Recurrent Non-Muscle Invasive Bladder Carcinoma

Alliance for Clinical Trials i

NCT06577441 Phase 2

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedaz...

Myelodysplastic Syndrome

United States, Puerto Rico

National Cancer Institute (NCI

NCT06701682 Phase 2

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...

Acute Respiratory Distress Syndrome (ARDS)

PPD Development, LP

NCT06208150 Phase 3

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, a...

Multiple Myeloma

United States, Argentina, Australia

Janssen Research & Development

NCT07285213 Phase 2

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...

Clostridioides Difficile Infection

United States, Australia, Canada

NCT05624450 Phase 3

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infec...

Viral Lung Infection and Acute Respiratory Failure

United States, Argentina, Australia

NCT04205968 Phase 2

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Metastatic Small Intestinal Adenocarcinoma

SWOG Cancer Research Network

NCT06592924 Phase 3

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...

Prostate Cancer (Adenocarcinoma)

United States, Canada

Canadian Cancer Trials Group

NCT07109869 Phase 3

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidia...

Vulvovaginal Candidiases

pH-D Feminine Health LLC

NCT07018869 Phase 3

Evaluating Whether an Educational Website Called Current Together After Cancer (...

Colorectal Cancer Stage II

United States, Guam, Puerto Rico

SWOG Cancer Research Network

NCT06919718 N/A

Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers...

Maternal Stress

University of Idaho

NCT06498635 Phase 3

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...

Lung Non-Small Cell Carcinoma

National Cancer Institute (NCI

NCT05963698 N/A

The Fourth Left Atrial Appendage Occlusion Study

Atrial Fibrillation

United States, Belgium, Canada

Hamilton Health Sciences Corpo

NCT06246916 Phase 3

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Partic...

United States, Canada

Regeneron Pharmaceuticals

NCT06827262 N/A

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

Chronic Low-back Pain

Boston Scientific Corporation

NCT05963074 Phase 2

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previous...

Leukemia, Lymphocytic, Chronic, B-Cell

United States, Canada, Czechia

Janssen Research & Development

NCT06283966 Phase 3

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...

COPD (Chronic Obstructive Pulmonary Disease)

United States, Argentina, Australia

NCT06937099 Phase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately t...

Crohn's Disease

United States, Austria, Belgium

Eli Lilly and Company

Page 1 of 2 — 41 trials total

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology